tiprankstipranks
Trending News
More News >

CIRC Partners with Qianlong International to Boost Nuclear Medicine Innovation

Story Highlights
CIRC Partners with Qianlong International to Boost Nuclear Medicine Innovation

Confident Investing Starts Here:

China Isotope & Radiation Corp. ( (HK:1763) ) just unveiled an announcement.

China Isotope & Radiation Corporation announced a strategic cooperation agreement with Qianlong International Holdings Limited to advance the application of boron neutron capture therapy technology and other nuclear medicine solutions. This collaboration aims to enhance public health through technological innovation and strengthen the high-end nuclear medicine industry in both domestic and international markets.

More about China Isotope & Radiation Corp.

China Isotope & Radiation Corporation (CIRC) operates in the nuclear medicine industry, focusing on the development and application of nuclear medical equipment, radiopharmaceuticals, and intelligent nuclear medicine solutions.

Average Trading Volume: 407,723

Technical Sentiment Signal: Buy

Current Market Cap: HK$4.73B

For an in-depth examination of 1763 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1